Weekly Spotlight - 07.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Predicting Duchenne Muscular Dystrophy Progression Through Genotype Analysis

Genetic variations can predict Duchenne muscular dystrophy progression, offering hope for tailored care. Certain genotypes, like exon 3-7 deletions, delay loss of mobility, while others, such as exon 51 mutations, worsen outcomes. This insight aids in designing trials and improving patient management, fostering optimism in treatment strategies.

Latest Gene Therapy Advances Offer Hope for Muscular Dystrophy Patients

The latest advancements in gene therapies for muscular dystrophy are promising, offering hope for patients. Key research includes editing muscle cells for dystrophin correction, innovative delivery methods, and new gene therapies. These breakthroughs, detailed in over 60 abstracts, highlight significant progress in treatment options, fostering optimism within the community.

New Hope for Duchenne Muscular Dystrophy with Emerging Drug Therapies

New therapies for Duchenne muscular dystrophy are transforming treatment options, offering hope. Eight FDA-approved drugs have emerged, with more in development. While corticosteroids remain vital, newer drugs like givinostat and vamorolone provide alternatives. These treatments, often mutation-specific, require careful patient assessment to maximise benefits and minimise side effects.

Chicago Marathon 2025: Join the Race to End Duchenne Team

Join the Race to End Duchenne team for the 2025 Chicago Marathon, celebrating its 20th anniversary. This fast, flat course offers a scenic tour of Chicago. Participants receive guaranteed entry, training resources, and support PPMD's mission. Fundraising deadline: 16 September 2025. Visit the official website for details.